Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/9/26 16:17 | 9/8/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Bergstrom Donald A | MA | O | P,R,D | 3 | S | -365 | 18.81 | 0 | -19 | 410 | D | |||||||||||||||
9/9/26 16:15 | 9/8/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Catinazzo Thomas | MA | O | CFO | 4 | S | -1,044 | 19.11 | 0 | -55 | 160 | D | |||||||||||||||
9/9/26 16:12 | 9/8/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Patel Sanjiv | MA | DO | P,CEO | 3 | S | -2,837 | 19.62 | 0 | -145 | 1,503 | D | |||||||||||||||
8/28/26 16:43 | 8/26/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Rahmer Peter | MA | O | See rema | 3 | S | -1,059 | 19.16 | 0 | -55 | 229 | D | |||||||||||||||
8/28/26 09:01 | 8/25/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Svf Pauling (Cayman) Ltd | T | 1 | S | -116,400 | 19.40 | 0 | -6,000 | 21,905 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |